Establishment of 2D Cell Cultures Derived From 3D MCF-7 Spheroids Displaying a Doxorubicin Resistant Profile

Area of Science:

• Cancer Research
• Drug Discovery
• Cell Biology

Background:

• In vitro 3D cancer spheroids mimic in vivo tumor drug resistance, making them valuable for anticancer compound screening.
• Current drug discovery methods are largely standardized for 2D cell cultures, posing a challenge for utilizing 3D models.
• There is a need for 2D cell culture models that exhibit drug resistance profiles similar to in vivo tumors.

Purpose of the Study:

• To develop a 2D cell culture model that replicates the drug-resistant phenotype of 3D cancer spheroids.
• To evaluate the efficacy of Doxorubicin (DOX) in a novel 2D cell culture system supplemented with glutathione (GSH).
• To investigate the mechanisms underlying enhanced drug resistance in these modified 2D cultures.

Main Methods:

• MCF-7 cells derived from 3D spheroids were cultured in 2D with medium supplemented with glutathione (GSH).
• The response of these 3D-derived 2D cultures to Doxorubicin (DOX) was evaluated.
• Key indicators of drug resistance, including P-glycoprotein (P-gp) activity and intracellular reactive oxygen species (ROS) production, were assessed.

Main Results:

• 3D-derived MCF-7 cells cultured in 2D with GSH exhibited significantly higher resistance to DOX compared to standard 2D cultures.
• The IC50 of DOX in GSH-supplemented 3D-derived 2D cultures was approximately eight times higher than in standard 2D cultures.
• This enhanced resistance was comparable to that observed in 3D MCF-7 spheroids, with only a two-fold difference in IC50.

Conclusions:

• Supplementing 2D cultures with glutathione (GSH) can successfully create a drug-resistant cancer cell model that mimics 3D spheroids.
• This approach allows the use of established 2D cell culture techniques for screening anticancer compounds against resistant tumor phenotypes.
• Increased P-glycoprotein (P-gp) activity and reduced intracellular reactive oxygen species (ROS) are potential mechanisms contributing to the observed drug resistance.